Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2022

May 18, 2022

34519_dirs_2022-05-18_f4e5784b-ba57-45da-be0d-6a3c917dc6b4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2022-02-11

Reporting Person: CRABB JOSEPH H (Former VP and CSO)